{"id":74279,"date":"2020-02-04T13:05:00","date_gmt":"2020-02-04T13:00:00","guid":{"rendered":"https:\/\/hispanicprwire.com\/english-outset-medical-announces-125-million-financing-led-by-d1-capital-partners\/"},"modified":"2020-02-04T14:09:01","modified_gmt":"2020-02-04T18:09:01","slug":"outset-medical-anuncia-financiamiento-por-125-millones-liderado-por-d1-capital-partners","status":"publish","type":"post","link":"https:\/\/hispanicprwire.com\/en\/outset-medical-anuncia-financiamiento-por-125-millones-liderado-por-d1-capital-partners\/","title":{"rendered":"Outset Medical Announces $125 Million Financing Led by D1 Capital Partners"},"content":{"rendered":"<p><\/p>\n<style type=\"text\/css\"><![CDATA[\n\/* Style Definitions *\/\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n]]><\/style>\n<div class=\"xn-content\">\n<p><span class=\"xn-location\">SAN JOSE, California<\/span>, <span class=\"xn-chron\">Feb. 4, 2020<\/span> \/PRNewswire-HISPANIC PR WIRE\/ &#8212;\u00a0Outset Medical, a leading medtech innovator delivering first-of-its-kind technology into the growing global dialysis market, today announced a <span class=\"xn-money\">$125 million<\/span> Series E equity financing round led by D1 Capital Partners. Fidelity Management and Research Company, Partner Fund Management, Perceptive Advisors, funds advised by T. Rowe Price Associates Inc., also are participating in the financing.<\/p>\n<div id=\"prni_dvprnejpg3ebaleft\" style=\"WIDTH: 100%; TEXT-ALIGN: left\" dir=\"ltr\"><img decoding=\"async\" id=\"prnejpg3ebaleft\" title=\"The Tablo Hemodialysis System\" border=\"0\" alt=\"The Tablo Hemodialysis System\" align=\"middle\" imagelabel=\"General\" src=\"https:\/\/mma.prnewswire.com\/media\/1004571\/Outset_Medical_Tablo.jpg\"\/><\/div>\n<p>Proceeds will be used to support commercial expansion of Outset Medical&#8217;s Tablo Hemodialysis System across the acute and chronic care markets in <span class=\"xn-location\">the United States<\/span>. Designed to reduce the cost and complexity of dialysis, Tablo expands how, when, and where dialysis can be provided.<\/p>\n<p>&#8220;We believe in Outset&#8217;s vision for technology-driven care delivery improvement, and Tablo&#8217;s ability to disrupt the dialysis market,&#8221; said <span class=\"xn-person\">Dan Sundheim<\/span>, Founder of D1 Capital Partners. &#8220;With growing focus at the federal level on how to manage Chronic Kidney Disease, which is increasingly prevalent, we believe Tablo is the only device with the potential to transform the delivery of dialysis.&#8221;<\/p>\n<p>Dialysis is delivered to more than 550,000 U.S. patients several times per week to remove waste products and excess fluid from patients with kidney failure. Although more than 85 million dialysis treatments take place in <span class=\"xn-location\">the United States<\/span> each year at an estimated annual cost of <span class=\"xn-money\">~$75 billion<\/span>, little meaningful technology or service model innovation has been introduced in decades.<\/p>\n<p>&#8220;Tablo&#8217;s unique, intuitive, all-in-one design offers healthcare systems, providers and patients a way to meaningfully improve the dialysis experience while also reducing costs,&#8221; said <span class=\"xn-person\">Leslie Trigg<\/span>, Outset Medical&#8217;s Chief Executive Officer. &#8220;We thank our investors for their continued support and look forward to deploying this capital to significantly impact the future of dialysis care.&#8221;<\/p>\n<p><b>About the Tablo Hemodialysis System<br \/><\/b><\/p>\n<p>Tablo is an FDA-cleared enterprise solution for dialysis, designed specifically to reduce the cost and complexity of dialysis across all care settings. Requiring only an electrical outlet and tap water to operate, the mobile Tablo system frees patients and providers from the burdensome infrastructure required to operate conventional dialysis machines.\u00a0 The machine&#8217;s integrated functionality enables it to serve as a dialysis clinic on wheels and enables providers to standardize to a single platform that can be used across a wide spectrum of care settings. Wireless data, sensor-based automation and an animated touchscreen make the system easy to learn and use.\u00a0 Leading health systems and medical centers across the U.S. have adopted Tablo for hospital and clinic dialysis, and the U.S. Department of Health and Human Services (HHS) awarded a contract for the use of Tablo in communities hit by natural disasters.<\/p>\n<p>Cooley LLP acted as legal advisor for Outset Medical in connection with the financing.<\/p>\n<p><b>About Outset Medical<\/b><\/p>\n<p>Outset Medical is dedicated to technology-driven service model innovation aimed at reducing cost and transforming the patient care experience. Outset&#8217;s Tablo System is FDA-cleared for use in acute and chronic care settings. In addition to its acute and chronic care commercial expansion, the company has concluded a clinical trial to expand Tablo&#8217;s labeled indication to include home use. For more information visit <a href=\"http:\/\/www.outsetmedical.com\" rel=\"nofollow\">www.outsetmedical.com<\/a>. <\/p>\n<p><b>About D1 Capital Partners<\/b><\/p>\n<p>D1 Capital LP is a global investment advisory firm that operates across public and private markets.\u00a0The firm combines the talent and operational excellence of a large, premier asset management firm with the flexible mandate and long-term time horizon of a family office.\u00a0Founded in 2017 by <span class=\"xn-person\">Daniel Sundheim<\/span>, D1 focuses on investing in the global internet, technology, telecom, media, consumer, healthcare, industrial, and real estate sectors.<\/p>\n<p>Photo &#8211; <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=2710491-1&amp;h=1649439537&amp;u=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1004571%2FOutset_Medical_Tablo.jpg&amp;a=https%3A%2F%2Fmma.prnewswire.com%2Fmedia%2F1004571%2FOutset_Medical_Tablo.jpg\" rel=\"nofollow\">https:\/\/mma.prnewswire.com\/media\/1004571\/Outset_Medical_Tablo.jpg<\/a> <\/p>\n<p>\u00a0<\/p>\n<p>SOURCE  Outset Medical<\/p>\n<\/div>\n<p> <\/p>","protected":false},"excerpt":{"rendered":"<div class=\"xn-content\">\n<p><span class=\"xn-location\">SAN JOSE, California<\/span>, <span class=\"xn-chron\">Feb. 4, 2020<\/span> \/PRNewswire-HISPANIC PR WIRE\/ &#8212;\u00a0Outset Medical, a leading medtech innovator delivering first-of-its-kind technology into the growing global dialysis market, today announced a <span class=\"xn-money\">$125 million<\/span> Series E equity financing round led by D1 Capital Partners. Fidelity Management and Research Company, Partner Fund Management, Perceptive Advisors, funds advised by T. Rowe Price Associates Inc., also are participating in the financing.<\/p>\n<p>&lt;div&#8230;<\/p>\n","protected":false},"author":1,"featured_media":74280,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[13],"tags":[],"class_list":["post-74279","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-salud"],"acf":[],"_links":{"self":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/74279","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/comments?post=74279"}],"version-history":[{"count":0,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/74279\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/media\/74280"}],"wp:attachment":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/media?parent=74279"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/categories?post=74279"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/tags?post=74279"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}